RxDoctor Payments Data

Lara El Khoury, MD

Rheumatology · Great Neck, NYNPI 1093125809

Payments from drug & device makers

What this record shows

That places this record below the midpoint for rheumatology clinicians in NY, where the typical reported total is $1,764.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$414,207in research payments, 2019–2025

Across 10 payments — averaging $41,421 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$221K
  • Amgen$193K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York

Medicare billing

Part B allowed, 2024
$75,828
Medicare patients
128
Services billed
3,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RasuvoMethotrexate/Pf11$5,870
Atovaquone16$5,046
Hydroxychloroquine Sulfate75$1,920
Prednisone177$1,052
MethotrexateMethotrexate Sodium33$725
Allopurinol75$505
Alendronate Sodium20$132
Omeprazole19$83
Pantoprazole Sodium11$65

Paid to pharmacies, not to this prescriber.

Other rheumatology in Great Neck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →